- American City Business Journals•21 minutes ago
Shares of Waltham-based diagnostics firm Alere fell 4 percent on Friday afternoon after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.
- The Wall Street Journal•2 hours ago
Alere Inc. escalated its fight with reluctant buyer Abbott Laboratories by filing a lawsuit against its potential acquirer to push it to move forward with the deal.
- Reuters•2 hours ago
Diagnostic-testing company Alere Inc said on Friday it sued Abbott Laboratories in an attempt to force the company to move ahead with its $5.8 billion takeover of Alere. Alere said the lawsuit seeks to compel Abbott to obtain all the antitrust approvals it needs to complete the deal. It said the complaint was filed Thursday in Delaware Chancery Court yesterday and should be made publicly available next week.
Alere Inc. (ALR)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||39.57 x 200|
|Ask||39.60 x 200|
|Day's Range||38.80 - 42.12|
|52wk Range||31.47 - 54.79|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-95.95|
|Avg Vol (3m)||1,039,695|
|Dividend & Yield||N/A (N/A)|